The not-so-hidden costs of steroid-toxicity
Worldwide, more than 50 million people – 1% of the adult population – are on long-term glucocorticoids (GC) [Fardet]. They are widely used as an inexpensive and readily available treatment for a ...
In conversation with... Michelle Petri MD MPH
“There has to be an acceptance that steroids are now an undesirable part of treating most rheumatic diseases, and our prescribing behavior must change.” Michelle Petri MD, MPH is a leading ...
Getting steroid sparing in the label: Measuring what matters in a Target Product Profile (TPP)
Steroid sparing and steroid avoidance have become important issues in modern medicine due to the toxic side effects of many common glucocorticoid therapies used to treat conditions ranging from ...
In conversation with... James T. Rosenbaum, MD
“Steroid toxicity is rampant and it can be fatal… bringing it onto the radar screen of the practicing physician is really, really important.” James T. Rosenbaum M.D. fell into ophthalmology by chance ...
The glucocorticoid toxicity index: Measuring change in glucocorticoid toxicity over time
Coping with steroid-toxicity has become an integral part of the treatment experience for patients with inflammatory disease for more than 70 years. With the development of new immunomodulatory ...
Curious about the true cost of steroid-toxicity?
Download our infographic today
